Generics

Filter

Current filters:

None

Popular Filters

1126 to 1150 of 1223 results

India’s Ranbaxy posts 3rd-qtr 2011 loss

10-11-2011

India’s largest drugmaker, Ranbaxy Laboratories (RANB: BO) posted its biggest quarterly loss in…

FinancialGenericsRanbaxy Laboratories

Letter to the Editor: Canadian intellectual property

10-11-2011

Dear, The Pharma Letter: The characterization of the CMAJ article by Paul Grootendorst and Aidan Hollis…

GenericsNorth AmericaPatentsPharmaceutical

Kohl-Grassley generic drug bill would save US taxpayers nearly $4.8 billion, says CBO

09-11-2011

A new estimate from the USA’s Congressional Budget Office (CBO) estimate finds that a bipartisan…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsPricing

Will the USA’s Hatch-Waxman lock be sprung in 2012? asks HP&M lawyer

08-11-2011

In the USA, there have been rumors for several weeks that, once the ball gets rolling in Congress with…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

Teva to continue selling Viagra generic in Russia

07-11-2011

Israel-basedTeva Pharmaceutical Industries (Nasdaq: TEVA) managed to avoid a high-profile confrontation…

DynamicoEuropeGenericsMarkets & MarketingPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

US Rep Bass introduces legislation to save taxpayer money under Medicaid

07-11-2011

US Congressman Charles Bass (Republican, New Hampshire) has introduced bipartisan legislation in the…

GenericsLegalNorth AmericaPricing

Generics giant Teva posts 3rd-qtr 2011 sales rise but net income down 13%

02-11-2011

The world’s largest generic drugs maker, Teva Pharmaceutical Industries (Nasdaq: TEVA), has reported…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Watson posts 23% rise in 3rd-qtr 2011 net revenue; ups forecast

01-11-2011

US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has reported net revenue of $1.1 billion for…

FinancialGenericsWatson Pharmaceuticals

Pres Obama orders FDA action to reduce Rx drug shortages in USA

01-11-2011

in frequency and severity in recent years and adversely affecting patient care. A small number of drugs…

GenericsNorth AmericaPharmaceuticalPoliticsRegulation

Australia’s GMiA completes Code review; comments on PBS cuts and vital role of pharma manufacturing

31-10-2011

Martin Cross, chairman of Australia’s Generic Medicines Industry Association (GMiA) has warned that…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalPricingRegulation

Brazil pharma market driven by generic medicines

31-10-2011

According to the Ministry of Health, the Brazilian pharmaceutical market has grown to $28 billion annually,…

GenericsMarkets & MarketingPharmaceuticalSouth America

Some 40% of G7 ESA markets to be biosimilars by 2020, and insulins to reach $1 billion, says DR report

30-10-2011

By 2020, biosimilar versions of erythropoietin stimulating agents (ESAs) will garner 40% market share…

BiotechnologyDiabetesGenericsGlobalMarkets & MarketingOncology

EuropaBio sets out views on biosimilars, saying they should not be treated like generics

27-10-2011

To contribute to an informed debate, the biotech trade group EuropaBio is launching a new brochure acknowledging…

BiotechnologyEuropeGenericsRegulation

Dr Reddy’s 2nd-qtr net profit and sales rises beats forecasts

26-10-2011

India’s second-largest drugmaker Dr Reddy’s Laboratories (NYSE: RDY) posted a strong set of…

Dr Reddy's LaboratoriesFinancialGenerics

28 pharma companies in USA entered potential pay-for-delay deals in FY 2011, says new FTC report

26-10-2011

In the 2011 fiscal year (12 months to September 30) pharmaceutical companies in the USA continued a recent…

GenericsNorth AmericaPatentsPharmaceuticalPolitics

Biostar Pharma sets out targets as it completes buy of Shaanxi Weinan

25-10-2011

Chinese drugmaker Biostar Pharmaceuticals (Nasdaq: BSPM) says that it has completed the previously-announced…

Asia-PacificBiostar PharmaGenericsMergers & AcquisitionsShaanxi Weinan

Irish drugmakers argue against ESRI Budget Perspectives (2012) proposals

24-10-2011

Budget Perspectives 2012, a paper published last week by the Economic and Social Research Institute (ESRI),…

EuropeGenericsHealthcarePharmaceuticalPricing

EU Commission opens antitrust proceedings against Johnson & Johnson and Novartis

24-10-2011

The European Commission revealed last Friday that it has opened an antitrust investigation, on its own…

EuropefentanylGenericsJohnson & JohnsonLegalNeurologicalNovartisPatentsPharmaceutical

On the issue of delaying generics, South Africa’s pharma market not comparable with the USA, expert says

23-10-2011

A recent report by the US competition authority, the Federal Trade Commission, on the short and long-term…

GenericsPatentsRest of the World

1126 to 1150 of 1223 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top